Staging of prostate cancer. Current TNM classification and future prospects for prognostic factors

Cancer

Volumn 75, Issue 7 S, 1995, Pages 1814-1818

  Montie, James E ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

prognostic factors; prostate cancer; staging; TNM system

Indexed keywords

BONE METASTASIS; BONE SCINTISCANNING; CANCER DIAGNOSIS; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; ECHOGRAPHY; FINGER; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; RECTUM;

EID: 0028909375     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19950401)75:7+<1814::AID-CNCR2820751610>3.0.CO;2-B     Document Type: Article

References (33)

1. New staging systems for prostate cancer
2. Digital rectal examination and cancer of the prostate
3. Interobserver variation in assessment of the prostate by digital rectal examination
4. Morphologic analysis of surgical margins with positive findings in prostatectomy for adenocarcinoma of the prostate
5. Adenocarcinoma of the prostate. Part II: tissue prognosticators
6. Correlation of pathologic findings with progression after radical retropubic prostatectomy
7. The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer
8. Staging of prostate cancer, value of ultrasonography
9. 1994 staging system for prostate cancer
10. Efficacy of transrectal ultrasound‐guided seminal vesicle biopsies in the detection of seminal vesicle invasion by prostate cancer
11. The use of prostate‐specific antigen in staging patients with newly diagnosed prostate cancer
12. Preoperative assessment of prostatic carcinoma by computerized tomography
13. Accuracy of combined computerized tomography and fine needle aspiration cytology in lymph node staging of localized prostate carcinoma
14. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer
15. Invasion of the neurovascular bundle by prostate cancer: evaluation with MR imaging
16. MR imaging in adenocarcinoma of the prostate: interobserver variation and efficacy for determining stage C disease
17. Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer
18. Fast spin‐echo MR images of the pelvis obtained with a phased‐array coil: value in localizing and staging prostate carcinoma
19. Clinical stage B0 or T1c prostate cancer: nonpalpable disease identified by elevated serum prostate‐specific antigen concentration
20. The new American Joint Committee on Cancer and International Union against Cancer TNM classification of prostate cancer
21. Tumor volume and stage in carcinoma of the prostate detected by elevations in prostate specific antigen
22. Predictive value of contralateral biopsies in unilaterally palpable prostate cancer
23. Systemic biopsies and digital rectal examination to identify the nerve‐sparing side for radical prostatectomy without risk of positive margin in patients with clinical stage T2,N0 prostatic carcinoma
24. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase‐polymerase chain reaction
25. The future of prognostic factors in outcome prediction for patients with cancer
26. Multiple prognostic factors and outcome analysis in patients with cancer
27. Statistical aspects of prognostic factor studies in oncology
28. The use of prostate specific antigen, clinical stage, and Gleason score to predict pathological stage in men with localized prostate cancer
29. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer
30. Artificial neural network in the diagnosis and prognosis of prostate cancer: a pilot study
31. Multiple prognostic factors and outcome analysis in patients with cancer